Genes in MS Patients Rensselaer NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

Robert K Rugen
518-758-1400
1002 Kinderhook St. 
Valatie, NY
Lee T Masterson
518-439-7644
204 Delaware Ave. 
Delmar, NY
Dennis F Corbett MD
(518) 374-4541
650 Franklin St
Schenectady, NY
Dr. Mike Wayne
518-371-4800
2 Emma Lane
Clifton Park, NY
Philip S Catalano
518-674-5272
36 Sunset Rd. 
Averill Park, NY
Piotr A Biegun, MD
(518) 268-5370
147 Hoosick St
Troy, NY
Andrea Kachidurian
518-477-6330
1542 Columbia Tpke. 
Castleton On Hudson, NY
Joseph S. Gulyas
(518) 371-4800
Northeast Spine
Clifton Park, NY
Mike Dudick, DC
(518) 664-2673
377 Route 146
Clifton Park, NY
Kenneth L Rabinoff-Goldman
518-768-2545
38 Morningstar Ln. 
Feura Bush, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Genetic Clues for Skin Cancer Therapies Rensselaer NY
Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.
- High Blood Pressure Genes Rensselaer NY
- Side Effect Of Chemotherapy Drugs Rensselaer NY
- Doctor-Patient Talk for Hypertension Rensselaer NY
- Differences Between Hospice and Palliative Care Rensselaer NY
- Gene Therapy for Parkinson's Rensselaer NY
- Exercise for Chemotherapy Patients Rensselaer NY
- Gene Variants and Alzheimer's Risk Rensselaer NY
- Depression in Heart Disease Patients Rensselaer NY
- Hospice: Getting Back Control of Your Life Rensselaer NY